newsfilter
← Latest News
GlobeNewswire·

Immuron Submits IMM-529 IND to FDA

Key Points Immuron submits Investigational new drug (IND) application to FDA for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI)Previous clinical